Perspectives in Drug Discovery and Design

6.4k citations
210 papers · · active since 1993

Impact in

Papers in

Perspectives in Drug Discovery and Design

195 papers receiving 5.8k citations

Peers

Perspectives in Drug Discovery and Design
Comparison fields: 5 of 154
  • Computational Theory and Mathematics 3k
  • Virology 108
  • Molecular Biology 1.4k
  • Infectious Diseases 411
  • Cancer Research 287
Replace Progress in medicinal chemistry with:
Progress in medicinal chemistry United Kingdom
WIREs Systems Biology and Medicine United States
Annual Review of Biophysics United States
BioMolecular Concepts United States
Current Pharmacology Reports United States
Drug Discovery Today Therapeutic Strategies United States
Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review India
Current Protocols in Pharmacology United States
Biochemistry Research International United States
Journal of Structural and Functional Genomics United States
Perspectives in Drug Discovery and Design relative to Progress in medicinal chemistry United Kingdom Progress in medicinal chemistry's profile →
Citations per field
00.5×2×3.1×
Progress in medicinal chemistry · 1×
Citations per year

Countries where authors publish in Perspectives in Drug Discovery and Design

Since Specialization
Citations

This map shows the geographic impact of research published in Perspectives in Drug Discovery and Design. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Perspectives in Drug Discovery and Design with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perspectives in Drug Discovery and Design more than expected).

Fields of papers published in Perspectives in Drug Discovery and Design

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Perspectives in Drug Discovery and Design. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Perspectives in Drug Discovery and Design.

About Perspectives in Drug Discovery and Design

The 210 papers published in Perspectives in Drug Discovery and Design in the last decades have received a total of 6.4k indexed citations . Papers published in Perspectives in Drug Discovery and Design usually cover Virology (23 papers), Computational Theory and Mathematics (86 papers), Cancer Research (19 papers), Transplantation (3 papers) and Molecular Biology (55 papers) specifically the topics of Computational Drug Discovery Methods (86 papers), HIV Research and Treatment (23 papers), Protease and Inhibitor Mechanisms (18 papers), Ion channel regulation and function (17 papers), HIV/AIDS drug development and treatment (12 papers), Chemical Synthesis and Analysis (8 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Signaling Pathways in Disease (7 papers). The most active scholars publishing in Perspectives in Drug Discovery and Design are Peter A. Kollman, Irina Massova, RICHARD D. III CRAMER, Gerhard Klebe, Krzysztof Appelt, Ingo Muegge, John Chung-Che Wu, Hugo Kubinyi, Peter W. Sprague and Michel Berthelot.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact